Updates to the Australian Pharmaceutical Benefits Scheme
22 May 2023
Update
Services Australia has published a release detailing new and amended listings of medications on the Australian Pharmaceutical Benefits Scheme (PBS), effective from 1 May 2023.
Amendments have been made to a range of medications on the PBS, including the following medications:
- Methylphenidate (Ritalin® LA) being amended to allow access for adults with a retrospective diagnosis of ADHD. This includes access to capsules containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg, 40 mg, 60mg (modified release).
- Naltrexone (Naltrexone GH®) having a reduction in authority level for the treatment of alcohol dependence.
Enquiries regarding new and amended listings can be directed to the PBS at pbs@health.gov.au.
More news & views

Crazy Socks 4 Docs Day 2025
Today marks CrazySocks4Docs Day, an initiative aimed at raising awareness and breaking down the stig...

Queensland Rural Readiness workshop highlights
The Rural Psychiatry Training Pathways team hosted the Queensland Rural Readiness workshop in Cairns...
02 June 2025
Welcoming our new President, Dr Astha Tomar
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) welcomes Dr Astha Tomar to th...